Drug Delivery for Anti-Infective Agents
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (20 January 2021) | Viewed by 57916
Special Issue Editor
Interests: delivery strategies for the prevention and treatment of leishmaniasis with special focus in non-parenteral (oral or topical) administration routes for the chemo-and immunotherapy of cutaneous leishmaniasis
Special Issue Information
Dear Colleagues,
The high prevalence of infective diseases, antimicrobial resistance and biofilm-associated infections on implantable devices have fueled the research for new and more effective treatments. New delivery strategies/materials/vehicles perform a promising platform for addressing this challenge. Meanwhile the discovering of new drugs is falling behind. Such vehicles can increase drug bioavailability and site-specific delivery, optimizing therapeutic index and dose-effect relationship. It would decrease the treatment duration and thus, the chance to acquire drug resistance.
The main objective of this special issue is to provide a review on the potential of such materials and vehicles in the treatment of infections. The vehicles can exhibit intrinsic antimicrobial properties (i.e. metallic particles) or serve as a cargo for delivering the anti-infective agents alone or in combination. They can facilitate the access of drugs to hard-to-reach locations such as intracellular pathogens, granulomas (i.e. tuberculosis) or deep dermal infections (i.e. leishmaniasis). Nanomaterials can also provide a high coating surface for decorating medical devices and avoid biofilm-associated infections. Finally, PK/PD analysis of these delivery systems could optimize the posology of drugs while preserving their efficacy.
Dr. María Socorro Espuelas Millán
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-infective agents
- micro- and nanoparticles (all materials)
- antimicrobial resistance
- biofilm
- PK/PD
- intracellular pathogens